Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "amgen rank"

Amgen Presents Positive Data At EHMTIC 2016 Demonstrating Erenumab Significantly Reduces Monthly Migraine...

Amgen announces phase 3 study of Xgeva in multiple myelom meet...

Amgen announced that a phase 3 study evaluating Xgeva (denosumab) versus zoledronic acid met the primary endpoint of non-inferiority (hazard ratio = 0.98, 95 per cent CI, 0.85 - 1.14) in delaying the time to first on-study skeletal-related event ... PharmaBiz, 4 days ago

Amgen's Xgeva matches zoledronic acid in late-stage study in multiple myeloma-related bone complications but falls short of showing superiority

Results from a Phase 3 clinical trial assessing Amgen's (NASDAQ: AMGN ) XGEVA (denosumab) compared to zoledronic acid (ZA) for the prevention of bone complications in newly diagnosed multiple myeloma (MM)patients achieved its primary endpoint. Full ...
 Seeking Alpha5 days ago
Financial Express

Dr Reddy's to market 3 Amgen drugs in India

To address needs in areas of oncology, osteoporosis Hyderabad, Sept 16: Pharma major Dr Reddy's Laboratories Ltd has expanded its collaboration with Amgen in India to market and distribute three of the latter's medicines in the domestic ...
 Hindu Business Line1 month ago Dr Reddy's inks pact with US-based Amgen to market three drugs in India  Firstpost.com1 month ago Dr Reddy's Laboratories inks pact with Amgen to commercialise three drugs in India  Economic Times1 month ago DRL inks pact with Amgen to market three drugs in India  Financial Express1 month ago

Coherus' Neulasta Biosimilar At FDA Altar, CytoDyn On Fast Track, VIVE Abuzz

Coherus BioSciences Inc.'s (CHRS) 351(k) Biologics License Application for CHS-1701, a proposed biosimilar to Amgen's (AMGN) blockbuster Neulasta, has been accepted for review by the FDA. Amgen's Neulasta boosts white blood cell count which ...
 RTTNews.com2 weeks ago Biosimilars in Limelight on FDA Approval of Amgen Drug  Zacks.com4 weeks ago FDA Okays Amgen's AMJEVITA For Treatment Of Seven Inflammatory Diseases  RTTNews.com1 month ago

Amgen's Multiple Myeloma Drug Kyprolis Fails in Phase III

Biotech major, Amgen, Inc. AMGN announced that its multiple myeloma drug Kyprolis did not meet the primary endpoint in a phase III head-to-head CLARION study with Velcade. The CLARION study (n=955) compared Kyprolis (carfilzomib) in combination ...
 Yahoo! Singapore4 weeks ago Amgen Inc. (AMGN) Is Down After Phase 3 Study Of Multiple Myeloma Drug Failed  RTTNews.com4 weeks ago Amgen Says Phase 3 CLARION Study In Multiple Myeloma Fails To Meet Primary Goal  RTTNews.com4 weeks ago

Amgen Investor Conference Call At 8:30 AM ET

Amgen Inc. (AMGN) will host a conference call at 8:30 AM ET on September 27, 2016, to discuss the CLARION data. To access the live webcast, log on at by RTT ...
 RTTNews.com4 weeks ago Amgen Analyst Meeting At 11:30 AM ET  RTTNews.com1 month ago Amgen Inc.'s (AMGN): Investor's Watch List  Equilibrio Informativo1 month ago

Pharmaceuticals Newsletter - September 12 to 16, 2016 [India Infoline News Service]

Top News Dr. Reddy's expands strategic collaboration with Amgen in India Dr. Reddy's Laboratories announced that it has expanded its strategic collaboration with Amgen, one of the world's leading independent biotechnology companies, to market and ...
 Pharmacy Choice1 month ago Dr. Reddy's collaborates with Amgen to commercialize its products in India  EHealth Magazine1 month ago Dr. Reddy's Expands Strategic Collaboration with Amgen in India  Equity Bulls1 month ago Dr. Reddy's Laboratories Ltd.???s Expands Strategic Collaboration With Amgen In India  BioSpace1 month ago

Amgen To Present At Citi Biotech R&D Conference; Webcast At 11:00 AM ET

Amgen Inc. (AMGN) will present at the Citi Biotech R&D Conference. The event is scheduled to begin at 11:00 AM ET on Oct. 7,2016. To access the live webcast, log on at by RTT Staff Writer For comments and feedback: ...
 RTTNews.com2 weeks ago

Amgen, Biogen, Gilead Could Skirt California Measure

A California ballot initiative requiring the state's Medicaid arm to buy drugs at comparable prices to what the U.S. Department of Veterans Affairs pays could backfire, thus preserving sales for the nation's biggest drugmakers, RBC analyst Michael ...
 Investor's Business Daily3 weeks ago

Amgen's Biosimilar of Abbvie's Humira Gets FDA Approval

Amgen, Inc. AMGN today announced the approval of Amjevita (adalimumab-atto), a biosimilar version to AbbVie Inc.'s ABBV rheumatoid arthritis (RA) drug Humira. Amjevita has been approved for the same indications that Humira is being used for ...
 Yahoo! Singapore4 weeks ago FDA Approves AMGN's 1st Biosimilar, MRNS On Track, All Ears For DRRX, PTIE  RTTNews.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less